The largest database of trusted experimental protocols

5 protocols using u46619

1

Immortalized Tubular Epithelial Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immortalized tubular epithelial cells (HK-2) were cultured in DMEM/F12 medium supplemented with 10% FBS. After synchronization, cells were treated with 20% FSGS patients’ serum (PS) or 40 nM C3a (204881, Merck-Calbiochem). For intervention studies, 1 μM of C3aR antagonist SB290157 (sc-222291, Santa Cruz), 100 μg/ml of eculizumab (Soliris, Alexion Pharmaceuticals), 10 μM of p38 MAPK inhibitor SB203580 (sc-3533, Santa Cruz), 50 μM of ERK inhibitor PD98059 (sc-3532, Santa Cruz), 10 μM of Akt inhibitor MK2206 (sc-364537, Santa Cruz) or 1 μM of U-46619 (sc-201242, Santa Cruz) was given 30 min before treatments. To infect HK-2 cells with plenti-CMV-LOC105375913, plenti-CMV-snail or plenti-CMV-XBP-1s plasmid, the lentiviral stock was mixed with polybrene (1 µg/ml) and added to cells. C/EBPβ siRNA (sc-44251), Elk-1 siRNA (sc-35290), ERα siRNA (sc-29305), GR siRNA (sc-35505), snail siRNA(sc-38398) and XBP-1s siRNA (sc-38627) were bought from Santa Cruz (Dallas, Texas, USA). LOC105375913 siRNA was bought from Thermo fisher (4390771, Carlsbad, California, USA). Transfection of siRNA, miRNA mimics or miRNA antisense oligonucleotide (ASO) was conducted with Lipofectamine 2000.
+ Open protocol
+ Expand
2

Fasudil and U46619 Transport Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasudil hydrochloride was purchased from FUJIFILM Wako Pure Chemical (Osaka, Japan). U46619, a thromboxane A2 (TXA2) receptor agonist, was purchased from Santa Cruz Biotechnology (Texas, USA). These compounds were administered into both luminal (upper) and abluminal side (lower compartment) of the cell culture inserts.
+ Open protocol
+ Expand
3

Neurodegeneration Mechanism Study Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly-L-lysine (PLL) (10x) was purchased from Beijing Solarbio Science and Technology Co., Ltd. (Beijing, China). DMEM/F12 (1 : 1), Neurobasal Plus Medium, B27 Plus Supplement (50x), HBSS (1x), FBS, and 0.25% trypsin were obtained from Gibco (Grand Island, New York, USA). The Aβ25-35 fragment and dimethyl sulfoxide (DMSO) were purchased from Sigma (St. Louis, MO, USA). Donepezil hydrochloride, SB203580, and U46619 were obtained from Santa Cruz Biotechnology Inc. (Delaware, USA). L-Glutamine was obtained from Thermo Fisher (Massachusetts, USA). The rabbit polyclonal antibodies against MAP2 were purchased from Proteintech Group, Inc. (Chicago, USA). Rabbit monoclonal antibodies against p38 MAPK, p-p38 MAPK, caspase-3, cleaved caspase-3, and Bax were purchased from Cell Signaling Technology (Beverly, MA, USA). The primary antibody against Bcl-2 was purchased from Abcam (Cambridge, UK). Horseradish peroxidase- (HRP-) conjugated IgG secondary antibody was purchased from Beijing Bioss Biotechnology Co., Ltd. (Beijing, China), and the BCA protein assay kit was obtained from Beyotime Biotechnological Technology Co., Ltd. (Shanghai, China).
+ Open protocol
+ Expand
4

In Vitro BBB Model OGD/R Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasudil hydrochloride was purchased from FUJIFILM Wako Pure Chemical (Osaka, Japan). U46619, a thromboxane A2 (TXA2) receptor agonist, was purchased from Santa Cruz Biotechnology (Texas, USA). These compounds were administered into both luminal (upper) and abluminal side (lower compartment) of the cell culture inserts.
In vitro oxygen-glucose deprivation and reoxygenation (OGD/R) studies on in vitro BBB model OGD/R experiments were performed as previously described with minor modi cation [28] . For 6-h OGD/24-h reoxygenation experiments, serum-free and glucose-free DMEM/F12 medium (Nakalai Tesque, Japan) which was bubbled with N2 gas was added to the BBB model. Oxygen deprivation was generated using Anaero Pack Kenki 5%® (Mitsubishi Gas Chemical Co., Inc., Tokyo, Japan). After 6-h OGD reoxygenation was initiated by changing the medium on the cells to RBEC medium. For normoxic condition, a similar procedure for OGD condition was performed except using serum-free and glucosecontaining (17.5 mM) DMEM/F12. Fasudil was added to the luminal and abluminal compartment of the BBB model at the start of reoxygenation. After 24-h reoxygenation experiments to test barrier integrity were performed.
+ Open protocol
+ Expand
5

Platelet Aggregation Induction Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
RWJ-56110 was purchased from Tocris Bioscience. HD-1 and HD-22 were from Protech Technology. Collagen (equine tendon) for induction of platelet aggregation was purchased from Helena Laboratories. PAR1 agonist peptide (SFLLRN-NH 2 [serine-phenylalanine-leucine-leucine-arginine-asparagine amide]), PAR4 agonist peptide (AYPGKF-NH 2 [alanine-tyrosine-proline-glycine-lysine-phenylalanine amide]), and the peptide GPRP-NH 2 (glycine-proline-arginineproline amide) were purchased from Bachem Bioscience. U46619, the antibodies for phospho-ERK (extracellular signal-regulated kinase; Tyr204), and actin were purchased from Santa Cruz Biotechnology. The antibodies for phospho-Akt (Thr308), phospho-p38 MAPK (mitogen-activated protein kinases) (Thr180/Tyr182), and phospho-(Ser) PKC (protein kinase C) substrates were purchased from Cell Signaling Technology. Human γ-thrombin was from Haematologic Technologies. Fluo-3/AM was purchased from Enzo Life Sciences. Dade Actin FSL activated partial thromboplastin time (APTT) reagent was purchased from Siemens. YD-3 was a kind gift from Prof Sheng-Chu Kuo at China Medical University, Taichung, Taiwan.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!